A new blood test called the Tick-Borne Disease Serochip (TBD Serochip) promises to revolutionize the diagnosis of tick-borne disease by offering a single test to identify and distinguish between ...
QIAGEN N.V. QGEN recently received Emergency Use Authorization (EUA) from the FDA for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Notably, the polymerase chain reaction (PCR) multiplex test will ...
(RTTNews) - Qiagen N.V. (QGEN) announced Monday that the U.S. Food and Drug Administration or FDA has granted Emergency Use Authorization for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test. The ...
A new test in development may be able to detect both COVID-19 and the flu at the same time. Continuing Coverage: Coronavirus in Wisconsin"It's a test that simultaneously looks for influenza and the ...
Aug. 15 (UPI) --The U.S. Food and Drug Administration has issued an Emergency Use Authorization for the first multiplex test for the Zika virus and three other viruses. The FDA made the authorization ...
MISSISSAUGA, Ontario, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio ...
Credit: Getty Images. The Alinity m STI Assay uses in vitro RT-PCR technology with high sensitivity to detect and differentiate STIs from symptomatic and asymptomatic individuals. The Food and Drug ...
The INSTI® Multiplex HIV-1/2 Syphilis Antibody Test delivers highly accurate results in just 60 seconds with a single sample—the fastest dual HIV/syphilis rapid test available. Now included in the ...
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the European launch of the NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test that ...
Examination of patients’ responses to direct-to-consumer genetic susceptibility tests is needed to inform clinical practice. This study examined patients’ recall and interpretation of, and responses ...
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the Emergency Use Authorization by the U.S. FDA for the NeuMoDx™ Flu A-B/RSV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback